Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers
Clinical trial NCT02184312 · COMPLETED
Trial details
- NCT number
- NCT02184312
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-07-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.